Lydia Ran is a seasoned product manager at VSK Medical Limited with expertise in the field of EECP Therapy (Enhanced External Counterpulsation). She pursued her Master's degree in Business Administration from Chongqing University and her Bachelor's degree in International Business English from the Chongqing University of Arts and Sciences. Lydia specializes in natural, noninvasive treatments for chronic stable angina and other heart diseases.

With over 1000 EECP systems in the US market and more than 300,000 patients benefiting worldwide from EECP therapy treatments, Lydia has proven clinical results showcasing the natural bypass, noninvasive, complementary, or alternative treatment prescribed by physicians and is cleared for marketing by the U.S. FDA as a Class II device for the treatment of patients.

Having completed many clinical studies, Lydia recognizes the incredible patient benefits of EECP therapy. These benefits include reducing or eliminating symptoms of chest pain, shortness of breath, fatigue, heart palpitation, leg pains from peripheral vascular disease, angina, and heart failure symptoms and classifications, strengthening the heart muscle, increasing perfusion, creating natural bypasses, and improving coronary perfusion.

Lydia is a staunch believer in EECP therapy and its merits. For further information on this therapy, you can reach her at lydiaran@eecp.com.cn or visit the website at www.vskmedical.com.